Commentary
Business & Economics
If ESG Enhances Profits, Then Why All The Fuss?
The Department of Labor finalized a rule last month that, as the Wall Street Journal editorial page noted, should not be controversial. The rule states that private pensions cannot let ancillary issues distract them from their primary mission of securing their beneficiaries’ retirement. Failure to achieve this mission jeopardizes the financial ...
Commentary
Big Pharma’s Hot Streak — and What Could Stop It
The pharmaceutical industry is on a bit of a hot streak. Last Monday, Pfizer announced promising results for its coronavirus vaccine. Later that day, Eli Lilly received emergency-use authorization from the FDA for its antibody treatment, which may prevent COVID-19 from growing serious in patients who contract the coronavirus and ...
Commentary
COVID-phobia – Americans should not fear routine medical care, they worry about not getting it
For America’s doctors, the greatest public health crisis in a generation has been incredibly bad for business. Eighty-one percent of physicians report that their revenues are still below pre-pandemic levels, according to a survey from the American Medical Association. A separate survey conducted earlier this spring found that only one-third of primary care ...
Business & Economics
San Francisco’s ‘CEO tax’ is bad economics, but threatens to spread
San Francisco voters have told CEOs and their businesses to take a long walk off a short pier into the bay. Not in those exact words but in their own way, by overwhelmingly approving Proposition L. Under the Overpaid Executive Tax, passed by a 65-35 ratio, the city will impose ...
Commentary
Big plans for BidenCare doomed if Republicans keep Senate majority
President-elect Joe Biden’s ambitious plan for a dramatic and costly overhaul of America’s health care sector that would start us down the road to socialized medicine and worse health care has no chance of approval if Republicans capture majority control of the U.S. Senate. And even if Democrats manage to control the Senate by ...
Commentary
Is there actually a underinsurance crisis?
Over two-fifths of adults went without adequate insurance coverage in the first half of this year, according to new research from the Commonwealth Fund. That includes more than 40 million who are “underinsured.” Those headline numbers are scary. They’re also misleading. Far too many Americans lack access to affordable health insurance. But that’s largely a function of government over-regulation. ...
Commentary
The key to stopping Biden’s healthcare plan: Gridlock
It looks like gridlock will be the norm in Washington for the next few years. And that just might be a good thing. While multiple news outlets have declared Joe Biden the winner of the presidential election, Republicans seem likely to control the Senate by one or two seats, as ...
Commentary
Biden His Time On Health Care?
It’s all but certain that Joe Biden will become the 46th president of the United States. Down the ballot, though, Democrats didn’t fare as well. They lost seats in the House. And Republicans appear poised to hold onto the Senate, provided they win at least one of two upcoming runoff ...
Commentary
Biden’s $750 billion health plan fixes nothing
Democrat Joe Biden made his plan for a new public government-run health insurance option a centerpiece of his presidential campaign. But another key provision of his health care agenda has gotten considerably less attention. The former vice president proposes to give taxpayer-subsidized coverage through Obamacare’s exchanges to more people — ...
Commentary
Fine-Tuning Treatments For COVID-19
President Trump’s COVID-19 recovery has thrust into the spotlight the possibilities of novel, experimental therapies for this potentially deadly disease. During his stay at Walter Reed National Military Medical Center, he was treated with at least three drugs that have since received substantial attention in the media: the anti-viral remdesivir, ...
If ESG Enhances Profits, Then Why All The Fuss?
The Department of Labor finalized a rule last month that, as the Wall Street Journal editorial page noted, should not be controversial. The rule states that private pensions cannot let ancillary issues distract them from their primary mission of securing their beneficiaries’ retirement. Failure to achieve this mission jeopardizes the financial ...
Big Pharma’s Hot Streak — and What Could Stop It
The pharmaceutical industry is on a bit of a hot streak. Last Monday, Pfizer announced promising results for its coronavirus vaccine. Later that day, Eli Lilly received emergency-use authorization from the FDA for its antibody treatment, which may prevent COVID-19 from growing serious in patients who contract the coronavirus and ...
COVID-phobia – Americans should not fear routine medical care, they worry about not getting it
For America’s doctors, the greatest public health crisis in a generation has been incredibly bad for business. Eighty-one percent of physicians report that their revenues are still below pre-pandemic levels, according to a survey from the American Medical Association. A separate survey conducted earlier this spring found that only one-third of primary care ...
San Francisco’s ‘CEO tax’ is bad economics, but threatens to spread
San Francisco voters have told CEOs and their businesses to take a long walk off a short pier into the bay. Not in those exact words but in their own way, by overwhelmingly approving Proposition L. Under the Overpaid Executive Tax, passed by a 65-35 ratio, the city will impose ...
Big plans for BidenCare doomed if Republicans keep Senate majority
President-elect Joe Biden’s ambitious plan for a dramatic and costly overhaul of America’s health care sector that would start us down the road to socialized medicine and worse health care has no chance of approval if Republicans capture majority control of the U.S. Senate. And even if Democrats manage to control the Senate by ...
Is there actually a underinsurance crisis?
Over two-fifths of adults went without adequate insurance coverage in the first half of this year, according to new research from the Commonwealth Fund. That includes more than 40 million who are “underinsured.” Those headline numbers are scary. They’re also misleading. Far too many Americans lack access to affordable health insurance. But that’s largely a function of government over-regulation. ...
The key to stopping Biden’s healthcare plan: Gridlock
It looks like gridlock will be the norm in Washington for the next few years. And that just might be a good thing. While multiple news outlets have declared Joe Biden the winner of the presidential election, Republicans seem likely to control the Senate by one or two seats, as ...
Biden His Time On Health Care?
It’s all but certain that Joe Biden will become the 46th president of the United States. Down the ballot, though, Democrats didn’t fare as well. They lost seats in the House. And Republicans appear poised to hold onto the Senate, provided they win at least one of two upcoming runoff ...
Biden’s $750 billion health plan fixes nothing
Democrat Joe Biden made his plan for a new public government-run health insurance option a centerpiece of his presidential campaign. But another key provision of his health care agenda has gotten considerably less attention. The former vice president proposes to give taxpayer-subsidized coverage through Obamacare’s exchanges to more people — ...
Fine-Tuning Treatments For COVID-19
President Trump’s COVID-19 recovery has thrust into the spotlight the possibilities of novel, experimental therapies for this potentially deadly disease. During his stay at Walter Reed National Military Medical Center, he was treated with at least three drugs that have since received substantial attention in the media: the anti-viral remdesivir, ...
